First azole-resistant Aspergillus fumigatus isolates with the environmental TR46 /Y121F/T289A mutation in Iran

Fatemeh Ahangarkani1,2, Ynze Puts2, Mojtaba Nabili3

  • 1Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.

Mycoses
|February 15, 2020
PubMed
Abstract

Insights

Azole-resistant Aspergillus fumigatus, a growing threat to invasive aspergillosis treatment, was detected in Iranian compost. This finding highlights the need for antifungal resistance surveillance in the region.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Environmental Microbiology

Background:

  • Azole resistance in Aspergillus fumigatus is a significant global health concern.
  • Triazole antifungals are crucial for treating invasive aspergillosis, making azole-resistant strains a clinical challenge.
  • Emerging azole resistance necessitates environmental monitoring to understand transmission dynamics.

Purpose of the Study:

  • To investigate the environmental prevalence of azole-resistant Aspergillus fumigatus in Iran.
  • To screen compost samples for the presence of resistant fungal strains.
  • To characterize the genetic basis of resistance in detected isolates.

Main Methods:

  • Screening of 300 compost samples from Northern Iran (2017-2018) using azole-containing agar.
  • Determination of phenotypic Minimum Inhibitory Concentrations (MICs) for confirmed isolates.
  • Sequencing of the cyp51A gene and microsatellite typing for genotypic analysis.

Main Results:

  • Three Aspergillus fumigatus isolates exhibited high voriconazole MICs (≥16 mg/L).
  • These isolates carried the TR46/Y121F/T289A mutation in the cyp51A gene.
  • Two isolates were genotypically related to Indian azole-resistant strains, while one had a distinct genotype.

Conclusions:

  • This study reports the first detection of Aspergillus fumigatus with the TR46/Y121F/T289A mutation in Iran.
  • Environmental surveillance identified azole-resistant strains, indicating a potential public health risk.
  • Ongoing monitoring of antifungal susceptibility in clinical Aspergillus fumigatus isolates from Iran and the region is recommended.